Space Exploration Technologies Corp. (NASDAQ: SPCX), or SpaceX, has now passed its post-IPO quiet period and the Wall Street underwriting firms have all been cleared to issue their slate of Buy, Sell and Neutral ratings and their respective price targets. Many of the reports are bullish, some are cautious, and some would be considered outliers.
While most price targets issued by brokerage firms are 12-month price targets, investors need to understand that these price targets on SpaceX are intended to reflect views that focus in many cases on developments and goals out to the year 2030 and beyond. Many of the opportunities and goals of SpaceX include, Starlink, AI in space, a move to the moon, and ultimately putting humans on Mars. It’s fair to assume that many of its goals may not even be visible or quantifiable until even beyond 2030.
Be advised that SpaceX equity price targets issued will undoubtedly change over time, based on earnings report and major developments that affect SpaceX, the overall race for space and AI, as well as many other factors.
EQUITY RATINGS
The reports are listed in alphabetical order by firm name and include dates of each report, the ratings and price targets. Justifications and upside/downside commentary have not been included to keep this report concise and to avoid showing any reports as more favorable or critical than others. Oggonomics does not issue formal ratings and price targets of its own on SpaceX and other individual stocks.
The SpaceX equity ratings and price targets (PT) are as follows:
- Argus Research (6/26) – Initiated Hold, no PT
- BofA Securities (7/07) – Initiated Buy, PT $235
- Bernstein (7/07) – Initiated Outperform, PT $239
- Cantor Fitzgerald (7/07) – Initiated Overweight, PT $246
- CFRA (6/12) – Initiated Sell, PT $115
- Citigroup (7/07) – Initiated Buy, PT $200
- Clear Street (7/07) – Initiated Buy, PT $217
- Daiwa Capital (7/02) – Initiated Neutral, PT $175
- Deutsche Bank (7/07) – Initiated Buy, PT $255
- Goldman Sachs (7/07) – Initiated Buy, PT $205
- JPMorgan (7/07) – Initiated Overweight, PT $225
- Macquarie (7/07) – Initiated Outperform, PT $250
- MoffettNathanson (7/07) – Initiated Neutral, PT $131
- Morgan Stanley (7/07) – Initiated Overweight, PT $300
- Needham (7/07) – Initiated Buy, PT $200
- Oppenheimer (6/12) – Initiated Outperform, PT $190
- Raymond James (7/07) – Initiated Strong Buy, PT $800
- RBC Capital Markets (7/07) – Initiated Outperform, PT $225
- Stifel (07/07) – Initiated Buy, PT $190
- Susquehanna (6/23) – Initiated Neutral, PT $170
- UBS (7/07) – Started at Buy, PT $210
- Wedbush (7/01) – Initiated Outperform, PT $190
- Wells Fargo (7/07) – Initiated Overweight, PT $230
- William Blair (7/07) – Initiated Outperform, no PT issued
CONSENSUS & OUTLIERS
If you add the price targets issued by the 22 firms with formal price targets, SpaceX would have a consensus price target of $236.27. There may be other firms with ratings and price targets that have not been seen that have not been factored into that “consensus” price target.
It is also fair to assume that some other price targets and ratings may exist that have not been covered in this report. The one standout price target of $800 (Raymond James) should also be considered an outlier target that may have added more than $30 to the consensus because the target is so far above the rest of the targets.
CREDIT RATINGS
Corporate Credit Ratings were issued on June 18, 2026, as follows:
- Fitch (6/18) assigned SpaceX a ‘BBB+’ rating with a ‘stable’ outlook.
- Moody’s (6/18) assigned SpaceX a ‘Baa1’ long-term issuer rating with a ‘stable’ outlook.
- S&P Global (6/18) assigned SpaceX a ‘BBB’ rating with a ‘stable’ outlook.
Morningstar (independent) does not have a formal rating but issued a “fair value estimate” of $62 pre-IPO.
